Abstract
Background
Access to treatment for glioblastoma (GBM) can be impacted by multiple demographic parameters. Barriers specific to the Hispanic population of the United States (US) are not fully understood. Therefore, the aim of this study was to elucidate geographic disparities for access to GBM treatment in the US Hispanic population.
Methods
All GBM patients with known Hispanic ethnicity status (and Caucasian race) in the US National Cancer Database (NCDB) between the years 2005–2016 were retrospectively reviewed. Treatment statuses of surgical resection, chemotherapy, radiation therapy and triple therapy (resection, chemotherapy and radiation) were summarized, and analyzed by comparison and regression analyses over US Census regions.
Results
A total cohort size of 40,232 Caucasian GBM patients were included, with 3,111 (8%) identifying as Hispanic. The odds of treatment by chemotherapy (OR 0.78, P < 0.01), radiation therapy (OR 0.82, P < 0.01) and triple therapy (OR 0.84, P < 0.01) were all significantly lower in the Hispanic group versus non-Hispanic group. The odds of being treated in the Hispanic group were significantly lower in multiple Census regions with respect to surgical resection (New England, OR 0.51; Mountain, OR 0.68), chemotherapy (East North Central, OR 0.77; Middle Atlantic, OR 0.71; Pacific, OR 0.77), radiation therapy (Middle Atlantic, OR 0.77) and triple therapy (New England, OR 0.49; Middle Atlantic, OR 0.87; Pacific, OR 0.84). Significant barriers to triple therapy in the Hispanic group within these regions were older age (OR 0.97; P < 0.01), treatment in a community facility (OR 0.85, P = 0.03), lack of insurance (OR 0.71, P = 0.03), yearly income < $40,227 (OR 0.69, P < 0.01), low education levels (OR 0.75, P = 0.03) and presence of co-morbidity (OR 0.82; P < 0.01).
Conclusions
Currently in the US, there exists heterogenous geographic disparities for Hispanic GBM patients to access different treatments compared to non-Hispanic patients. Multiple circumstances can influence access to treatment within the Hispanic community of these regions, and greater investigation with more granularity required to reveal mechanisms in which these disparities may be addressed in the future.
Similar content being viewed by others
References
Mojica CM, Flores B, Ketchum NS, Liang Y (2017) Health care access, utilization, and cancer screening among low-income Latina Women. Hisp Health Care Int 15(4):160–165. https://doi.org/10.1177/1540415317735343
Alvarez E, Keegan T, Johnston EE, Haile R, Sanders L, Saynina O, Chamberlain LJ (2017) Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers. Cancer 123(13):2516–2523. https://doi.org/10.1002/cncr.30562
Yanez B, McGinty HL, Buitrago D, Ramirez AG, Penedo FJ (2016) Cancer outcomes in Hispanics/Latinos in the United States: an integrative review and conceptual model of determinants of health. J Lat Psychol 4(2):114–129. https://doi.org/10.1037/lat0000055
Siegel RL, Fedewa SA, Miller KD, Goding-Sauer A, Pinheiro PS, Martinez-Tyson D (2015) Jemal A (2015) Cancer statistics for Hispanics/Latinos. CA Cancer J Clin 65(6):457–480. https://doi.org/10.3322/caac.21314
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. https://doi.org/10.1056/NEJMoa043330
Weller M (2018) Next generation neuro-oncology. Eur J Cancer 96:1–5. https://doi.org/10.1016/j.ejca.2018.03.016
Shergalis A, Bankhead A 3rd, Luesakul U, Muangsin N, Neamati N (2018) Current challenges and opportunities in treating glioblastoma. Pharmacol Rev 70(3):412–445. https://doi.org/10.1124/pr.117.014944
Chandra A, Rick JW, Dalle Ore C, Lau D, Nguyen AT, Carrera D, Bonte A, Molinaro AM, Theodosopoulos PV, McDermott MW, Berger MS, Aghi MK (2018) Disparities in health care determine prognosis in newly diagnosed glioblastoma. Neurosurg Focus 44(6):E16. https://doi.org/10.3171/2018.3.Focus1852
Mukherjee D, Zaidi HA, Kosztowski T, Chaichana KL, Brem H, Chang DC, Quinones-Hinojosa A (2010) Disparities in access to neuro-oncologic care in the United States. Arch Surg 145(3):247–253. https://doi.org/10.1001/archsurg.2009.288
Mukherjee D, Kosztowski T, Zaidi HA, Jallo G, Carson BS, Chang DC, Quinones-Hinojosa A (2009) Disparities in access to pediatric neurooncological surgery in the United States. Pediatrics 124(4):e688–696. https://doi.org/10.1542/peds.2009-0377
Mukherjee D, Zaidi HA, Kosztowski T, Chaichana KL, Salvatori R, Chang DC, Quinones-Hinojosa A (2009) Predictors of access to pituitary tumor resection in the United States, 1988–2005. Eur J Endocrinol 161(2):259–265. https://doi.org/10.1530/eje-09-0043
Lerro CC, Robbins AS, Phillips JL, Stewart AK (2013) Comparison of cases captured in the national cancer data base with those in population-based central cancer registries. Ann Surg Oncol 20(6):1759–1765. https://doi.org/10.1245/s10434-013-2901-1
Dressler EV, Liu M, Garcia CR, Dolecek TA, Pittman T, Huang B, Villano JL (2019) Patterns and disparities of care in glioblastoma. Neurooncol Pract 6(1):37–46. https://doi.org/10.1093/nop/npy014
Rhome R, Fisher R, Hormigo A, Parikh RR (2016) Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma. J Neurooncol 128(2):241–250. https://doi.org/10.1007/s11060-016-2101-5
Jaiswal K, Hull M, Furniss AL, Doyle R, Gayou N, Bayliss E (2018) Delays in diagnosis and treatment of breast cancer: a safety-net population profile. J Natl Compr Canc Netw 16(12):1451–1457. https://doi.org/10.6004/jnccn.2018.7067
Ikoma N, Cormier JN, Feig B, Du XL, Yamal JM, Hofstetter W, Das P, Ajani JA, Roland CL, Fournier K, Royal R, Mansfield P, Badgwell BD (2018) Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: analysis of the national cancer data base, 2006–2014. Cancer 124(5):998–1007. https://doi.org/10.1002/cncr.31155
Liederbach E, Lewis CM, Yao K, Brockstein BE, Wang C-H, Lutfi W, Bhayani MK (2015) A contemporary analysis of surgical trends in the treatment of squamous cell carcinoma of the oropharynx from 1998 to 2012: a report from the national cancer database. Ann Surg Oncol 22(13):4422–4431. https://doi.org/10.1245/s10434-015-4560-x
Caram MEV, Ross R, Lin P, Mukherjee B (2019) Factors associated with use of sipuleucel-t to treat patients with advanced prostate cancer. JAMA Netw Open 2(4):e192589–e192589. https://doi.org/10.1001/jamanetworkopen.2019.2589
Pan IW, Ferguson SD, Lam S (2015) Patient and treatment factors associated with survival among adult glioblastoma patients: a USA population-based study from 2000–010. J Clin Neurosci 22(10):1575–1581. https://doi.org/10.1016/j.jocn.2015.03.032
Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS (2018) Adult glioma incidence and survival by race or ethnicity in the united states from 2000 to 2014. JAMA Oncol 4(9):1254–1262. https://doi.org/10.1001/jamaoncol.2018.1789
Wu C-C, Wang TJC, Jani A, Estrada JP, Ung T, Chow DS, Soun JE, Saad S, Qureshi YH, Gartrell R, Saadatmand HJ, Saraf A, Garrett MD, Grubb CS, Isaacson SR, Cheng SK, Sisti MB, Bruce JN, Sheth SA, Lassman AB, McKhann GM 2nd (2016) A modern radiotherapy series of survival in hispanic patients with glioblastoma. World Neurosurg 88:260–269. https://doi.org/10.1016/j.wneu.2015.12.081
Tang J, Shao W, Dorak MT, Li Y, Miike R, Lobashevsky E, Wiencke JK, Wrensch M, Kaslow RA, Cobbs CS (2005) Positive and negative associations of human leukocyte antigen variants with the onset and prognosis of adult glioblastoma multiforme. Cancer Epidemiol Biomarkers Prev 14(8):2040–2044. https://doi.org/10.1158/1055-9965.EPI-05-0136
Shabihkhani M, Telesca D, Movassaghi M, Naeini YB, Naeini KM, Hojat SA, Gupta D, Lucey GM, Ontiveros M, Wang MW, Hanna LS, Sanchez DE, Mareninov S, Khanlou N, Vinters HV, Bergsneider M, Nghiemphu PL, Lai A, Liau LM, Cloughesy TF, Yong WH (2017) Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma. J Neurooncol 132(2):351–358. https://doi.org/10.1007/s11060-017-2377-0
Brown DA, Himes BT, Kerezoudis P, Chilinda-Salter YM, Grewal SS, Spear JA, Bydon M, Burns TC, Parney IF (2018) Insurance correlates with improved access to care and outcome among glioblastoma patients. Neuro Oncol 20(10):1374–1382. https://doi.org/10.1093/neuonc/noy102
Edward J, Morris S, Mataoui F, Granberry P, Williams MV, Torres I (2018) The impact of health and health insurance literacy on access to care for Hispanic/Latino communities. Public Health Nurs 35(3):176–183. https://doi.org/10.1111/phn.12385
Ghaddar S, Byun J, Krishnaswami J (2018) Health insurance literacy and awareness of the affordable care act in a vulnerable Hispanic population. Patient Educ Couns 101(12):2233–2240. https://doi.org/10.1016/j.pec.2018.08.033
van der Goes DN, Santos R (2018) Determinants of private health insurance coverage among Mexican American men 2010–2013. J Med Econ 21(11):1139–1143. https://doi.org/10.1080/13696998.2018.1515083
O'Connor JM, Sedghi T, Dhodapkar M, Kane MJ, Gross CP (2018) Factors associated with cancer disparities among low-, medium-, and high-income US Counties. JAMA Netw Open 1(6):e183146. https://doi.org/10.1001/jamanetworkopen.2018.3146
Akee R, Jones MR, Porter SR (2019) Race matters: income shares, income inequality, and income mobility for all US races. Demography 56(3):999–1021. https://doi.org/10.1007/s13524-019-00773-7
Villanueva C, Chang J, Bartell SM, Ziogas A, Bristow R, Vieira VM (2019) Contribution of geographic location to disparities in ovarian cancer treatment. J Natl Compr Canc Netw 17(11):1318–1329. https://doi.org/10.6004/jnccn.2019.7325
Kamara D, Weil J, Youngblom J, Guerra C, Joseph G (2018) Cancer counseling of low-income limited english proficient latina women using medical interpreters: implications for shared decision-making. J Genet Couns 27(1):155–168. https://doi.org/10.1007/s10897-017-0132-5
Ilowite MF, Cronin AM, Kang TI, Mack JW (2017) Disparities in prognosis communication among parents of children with cancer: the impact of race and ethnicity. Cancer 123(20):3995–4003. https://doi.org/10.1002/cncr.30960
Cadet TJ, Burke SL, Stewart K, Howard T, Schonberg M (2017) Cultural and emotional determinants of cervical cancer screening among older Hispanic women. Health Care Women Int 38(12):1289–1312. https://doi.org/10.1080/07399332.2017.1364740
Bakk L, Cadet TJ (2018) Awareness of the medicare part D low-income subsidy among older non-Hispanic blacks and Hispanics. Soc Work Public Health 33(4):250–258. https://doi.org/10.1080/19371918.2018.1462285
Miller KD, Goding Sauer A, Ortiz AP, Fedewa SA, Pinheiro PS, Tortolero-Luna G, Martinez-Tyson D, Jemal A (2018) Siegel RL (2018) Cancer statistics for Hispanics/Latinos. CA Cancer J Clin 68(6):425–445. https://doi.org/10.3322/caac.21494
Manuel JI (2018) Racial/ethnic and gender disparities in health care use and access. Health Serv Res 53(3):1407–1429. https://doi.org/10.1111/1475-6773.12705
Cardona AF, Rojas L, Wills B, Bernal L, Ruiz-Patiño A, Arrieta O, Hakim EJ, Hakim F, Mejía JA, Useche N, Bermúdez S, Carranza H, Vargas C, Otero J, Mayor LC, Ortíz LD, Franco S, Ortíz C, Gil-Gil M, Balaña C, Zatarain-Barrón ZL (2018) Efficacy and safety of Levetiracetam vs other antiepileptic drugs in Hispanic patients with glioblastoma. J Neurooncol 136(2):363–371. https://doi.org/10.1007/s11060-017-2660-0
Dickmann LJ, Schutzman JL (2018) Racial and ethnic composition of cancer clinical drug trials: how diverse are we? Oncologist 23(2):243–246. https://doi.org/10.1634/theoncologist.2017-0237
Duong C, Nguyen T, Sheppard JP, Ong V, Chung LK, Nagasawa DT, Yang I (2017) Genomic and molecular characterization of brain tumors in asian and non-asian patients of Los Angeles: a single institution analysis. Brain Tumor Res Treat 5(2):64–69. https://doi.org/10.14791/btrt.2017.5.2.64
Martinez Tyson D, Medina-Ramirez P, Flores AM, Siegel R, Aguado Loi C (2018) Unpacking hispanic ethnicity-cancer mortality differentials among hispanic subgroups in the United States, 2004–2014. Front Public Health 6:219. https://doi.org/10.3389/fpubh.2018.00219
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The project described was supported by the National Center For Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002736 (M.E.I.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All other authors report no funding sources or conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lu, V.M., Shah, A.H., Eichberg, D.G. et al. Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: Insights from a national database. J Neurooncol 147, 711–720 (2020). https://doi.org/10.1007/s11060-020-03480-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-020-03480-1